NASDAQ

GeneDx Holdings Corp. - Class A (WGS)

678 Thanks from members

GeneDx Holdings Corp. (WGS) displays mixed financial sentiment, balancing strong Q2 2026 exome and genome volume growth and early adjusted profitability with significant headwinds, including a $31.2 million Fabric Genomics write-off, guidance cuts, and an ongoing securities class action lawsuit.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →